Bordetella petrii and Zoonotic Respiratory Infection

In many pet-owning households, companion animals provide comfort and companionship, yet they may also carry microorganisms capable of crossing species barriers. Bordetella petrii represents one such organism. Commonly associated with respiratory colonization in animals, it has also been reported as an opportunistic zoonotic pathogen capable of infecting humans. In veterinary medicine, members of the genus Bordetella are recognized for their role in canine infectious tracheobronchitis (“kennel cough”), while occasional human infections highlight their broader clinical relevance.

Bordetella petrii belongs to the Phylum Proteobacteria, Class Betaproteobacteria, Order Burkholderiales, Family Alcaligenaceae, Genus Bordetella. It is a Gram-negative coccobacillus that grows under aerobic or facultatively anaerobic conditions.

Cells are small and typically appear singly or in pairs under microscopic observation. Several biological characteristics contribute to its ability to colonize host respiratory tissues:

• Genomic Variability: The genome displays notable plasticity, which may support adaptation to different hosts and environmental conditions.
• Host Association: The bacterium primarily colonizes the respiratory mucosa of mammals, including dogs and other small animals.
• Adhesion Mechanisms: Surface adhesins such as pili and filamentous hemagglutinin facilitate attachment to respiratory epithelial cells, an essential step in colonization and infection.

The primary natural hosts of Bordetella petrii include dogs and other companion animals such as cats, rabbits, and guinea pigs. Colonization occurs mainly in the respiratory tract, where the organism may persist asymptomatically or contribute to respiratory disease.

Transmission typically occurs through respiratory droplets or aerosols. In animal populations—particularly in crowded environments such as kennels or shelters—coughing and sneezing can facilitate rapid spread. Humans may acquire infection through close contact with symptomatic animals or exposure to contaminated respiratory secretions.

Individuals with occupational exposure, including veterinarians, animal handlers, and kennel workers, as well as immunocompromised pet owners, may have an increased risk of infection.

In animals, particularly dogs, Bordetella species are major contributors to infectious tracheobronchitis. In humans, infections remain relatively uncommon but may present with a range of clinical manifestations.

• Respiratory Infection: Manifestations range from mild upper respiratory illness to bronchitis or pneumonia, particularly in elderly or immunocompromised individuals.
• Bacteremia and Sepsis: Rare but severe cases have been reported in patients with underlying diseases.
• Other Infections: Occasional cases include endocarditis, meningitis, peritonitis, ocular infection, or wound infection.

A notable clinical feature is that many human cases are associated with a documented history of close contact with symptomatic pets.

Diagnosis may be challenging because clinical manifestations are nonspecific and bacterial isolation can be difficult.

Culture: Specimens such as sputum, bronchoalveolar lavage fluid, or blood may be cultured. However, growth can be slow and may require specialized conditions, often leading to underdiagnosis.

Molecular Detection: PCR-based methods allow rapid and sensitive detection of bacterial DNA directly from clinical samples. Probe-based real-time PCR assays are particularly useful for confirming the presence of Bordetella petrii in respiratory or environmental specimens.

Serological Testing: Detection of specific antibodies may support retrospective diagnosis or epidemiological investigations.

Antimicrobial treatment should be guided by susceptibility testing because intrinsic resistance to several commonly used antibiotics has been reported.

• Resistance Patterns: Reduced susceptibility has been observed for certain β-lactams, macrolides, aminoglycosides, and trimethoprim.
• Active Agents: Fluoroquinolones, broad-spectrum cephalosporins, tetracyclines, piperacillin-tazobactam, and carbapenems may demonstrate activity against susceptible isolates.
• Treatment Strategy: Severe infections such as pneumonia generally require prolonged antimicrobial therapy based on susceptibility testing.

Management should also include treatment of infected animals and environmental hygiene measures to prevent reinfection.

Bordetella petrii illustrates the complex relationship between companion animals and human health. As a potential zoonotic pathogen, it highlights the importance of integrated approaches to disease surveillance and prevention.

With the growing popularity of companion animals, awareness of zoonotic respiratory pathogens is increasingly important. Collaboration between medical and veterinary disciplines—consistent with the “One Health” framework—will be essential for early detection, effective treatment, and risk reduction.

Related Product

Bordetella petrii Probe Realtime PCR Kit

Catalog No.: 15-12270

Probe-based real-time PCR supports rapid and specific detection of Bordetella petrii in respiratory or environmental samples for microbiological research and surveillance.

Cautions:
For research use only.
Not intended for diagnostic or therapeutic use unless otherwise specified.